BioMedWorks’ Newsletter
Subscribe
Sign in
Share this discussion
FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver disease
biomedworks.substack.com
Copy link
Facebook
Email
Note
Other
FDA approves Madrigal’s NASH drug, marking…
BioMedWorks
Mar 14
3
Share this post
FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver disease
biomedworks.substack.com
Copy link
Facebook
Email
Note
Other
This thyroid hormone analogue, resmetirom, gets marketing approval.
Read →
0 Comments
Share
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver disease
FDA approves Madrigal’s NASH drug, marking…
FDA approves Madrigal’s NASH drug, marking the first-ever treatment for the liver disease
This thyroid hormone analogue, resmetirom, gets marketing approval.